Ulrich Klar

1.4k total citations
41 papers, 951 citations indexed

About

Ulrich Klar is a scholar working on Oncology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Ulrich Klar has authored 41 papers receiving a total of 951 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 14 papers in Organic Chemistry and 11 papers in Molecular Biology. Recurrent topics in Ulrich Klar's work include Cancer Treatment and Pharmacology (18 papers), Microtubule and mitosis dynamics (10 papers) and Estrogen and related hormone effects (6 papers). Ulrich Klar is often cited by papers focused on Cancer Treatment and Pharmacology (18 papers), Microtubule and mitosis dynamics (10 papers) and Estrogen and related hormone effects (6 papers). Ulrich Klar collaborates with scholars based in Germany, United States and Switzerland. Ulrich Klar's co-authors include Jens Hoffmann, Rosemarie B. Lichtner, Wolfgang Schwede, Anette Sommer, Werner Skuballa, Bernd Buchmann, Keith Graham, Aileen Höhne, Ulrike Voigtmann and Linjing Mu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and SHILAP Revista de lepidopterología.

In The Last Decade

Ulrich Klar

39 papers receiving 919 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ulrich Klar Germany 17 482 355 228 214 164 41 951
Venkat R. Pallela United States 17 208 0.4× 246 0.7× 186 0.8× 278 1.3× 49 0.3× 25 738
Susan Ashton United Kingdom 14 521 1.1× 580 1.6× 108 0.5× 236 1.1× 54 0.3× 25 1.2k
Cécile Combeau France 13 339 0.7× 431 1.2× 67 0.3× 81 0.4× 343 2.1× 22 1.0k
Ashutosh Pal United States 16 340 0.7× 525 1.5× 203 0.9× 130 0.6× 51 0.3× 44 983
Satish K. Chitneni United States 16 179 0.4× 365 1.0× 224 1.0× 125 0.6× 36 0.2× 42 880
Diane Teague United States 12 579 1.2× 317 0.9× 70 0.3× 61 0.3× 145 0.9× 14 1.1k
Mark D. Hylarides United States 20 259 0.5× 297 0.8× 716 3.1× 171 0.8× 62 0.4× 49 1.1k
Mark Frigerio United Kingdom 15 428 0.9× 638 1.8× 227 1.0× 382 1.8× 45 0.3× 22 1.2k
K. M. Błażewska Poland 19 315 0.7× 433 1.2× 89 0.4× 288 1.3× 101 0.6× 43 962
Sylvia Musto United States 18 328 0.7× 466 1.3× 165 0.7× 216 1.0× 160 1.0× 32 943

Countries citing papers authored by Ulrich Klar

Since Specialization
Citations

This map shows the geographic impact of Ulrich Klar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrich Klar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrich Klar more than expected).

Fields of papers citing papers by Ulrich Klar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrich Klar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrich Klar. The network helps show where Ulrich Klar may publish in the future.

Co-authorship network of co-authors of Ulrich Klar

This figure shows the co-authorship network connecting the top 25 collaborators of Ulrich Klar. A scholar is included among the top collaborators of Ulrich Klar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrich Klar. Ulrich Klar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Möller, Carsten, Wilhelm Bone, Arwed Cleve, et al.. (2018). Discovery of Vilaprisan (BAY 1002670): A Highly Potent and Selective Progesterone Receptor Modulator Optimized for Gynecologic Therapies. ChemMedChem. 13(21). 2271–2280. 26 indexed citations
2.
Wengner, Antje M., Gerhard Siemeister, Marcus Koppitz, et al.. (2016). Novel Mps1 Kinase Inhibitors with Potent Antitumor Activity. Molecular Cancer Therapeutics. 15(4). 583–592. 85 indexed citations
3.
Klar, Ulrich, et al.. (2015). Biocatalysis at Work: Applications in the Development of Sagopilone. ChemMedChem. 10(7). 1240–1248. 5 indexed citations
4.
5.
Hammer, Stefanie, Anette Sommer, Iduna Fichtner, et al.. (2010). Comparative Profiling of the Novel Epothilone, Sagopilone, in Xenografts Derived from Primary Non–Small Cell Lung Cancer. Clinical Cancer Research. 16(5). 1452–1465. 34 indexed citations
6.
Suominen, Mari I., Jukka P. Rissanen, Dominik Mumberg, et al.. (2010). The anti-tumor agent sagopilone shows antiresorptive effects both in vitro and in vivo. Osteoporosis International. 22(11). 2887–2893. 4 indexed citations
7.
8.
Hoffmann, Jens, et al.. (2009). Sagopilone Inhibits Breast Cancer Bone Metastasis and Bone Destruction Due to Simultaneous Inhibition of Both Tumor Growth and Bone Resorption. Clinical Cancer Research. 15(11). 3751–3759. 16 indexed citations
9.
Höhne, Aileen, Linjing Mu, Michael Honer, et al.. (2008). Synthesis, 18F-Labeling, and in Vitro and in Vivo Studies of Bombesin Peptides Modified with Silicon-Based Building Blocks. Bioconjugate Chemistry. 19(9). 1871–1879. 110 indexed citations
10.
Hoffmann, Jens, Iduna Fichtner, M Lemm, et al.. (2008). Sagopilone crosses the blood–brain barrier in vivo to inhibit brain tumor growth and metastases. Neuro-Oncology. 11(2). 158–166. 60 indexed citations
11.
Hammer, Suntrea T.G., Natalie Arnold, Felix Hilpert, et al.. (2007). 5009 ORAL Significant antitumour activity of the novel epothilone ZK-EPO against in vitro and in vivo models of ovarian cancer. European Journal of Cancer Supplements. 5(4). 313–314. 3 indexed citations
12.
Hoffmann, Jens, Bernd Buchmann, Wolfgang Schwede, et al.. (2005). New synthetic Epothilone Derivative ZK-EPO inhibits breast cancer metastasis. Cancer Research. 65. 807–807. 6 indexed citations
13.
Klar, Ulrich, et al.. (2005). Efficient Chiral Pool Synthesis of the C1-C6 Fragment of Epothilones. Synthesis. 2005(2). 301–305. 18 indexed citations
14.
Cleve, Arwed, Ulrich Klar, & Wolfgang Schwede. (2004). Beneficial effects of fluorine in the anti-progestin ZK 230211. Journal of Fluorine Chemistry. 126(2). 217–220. 14 indexed citations
15.
Klar, Ulrich, Werner Skuballa, Bernd Buchmann, et al.. (2002). ChemInform Abstract: Synthesis and Biological Activity of Epothilones. ChemInform. 33(25). 6 indexed citations
16.
Klar, Ulrich, et al.. (1998). New synthetic inhibitors of microtubule depolymerization. Bioorganic & Medicinal Chemistry Letters. 8(11). 1397–1402. 34 indexed citations
17.
Klar, Ulrich, Günter Neef, & Helmut Vorbrüggen. (1996). Perfluorobutanesulfonyl fluoride — 1,8-diazabicyclo[5.4.0]undec-7-ene as a useful system in diol-epoxide transformation. Tetrahedron Letters. 37(42). 7497–7498. 8 indexed citations
18.
Klar, Ulrich, et al.. (1995). Novel prostanoid thromboxane A2 antagonists. Bioorganic & Medicinal Chemistry Letters. 5(12). 1219–1224. 3 indexed citations
19.
Klar, Ulrich, et al.. (1995). Novel prostanoid thromboxane A2 agonists. Prostaglandins. 50(2). 57–63. 1 indexed citations
20.
Klar, Ulrich, et al.. (1992). Synthesis of potent 6-oxo and 9-fluoro-PGE1-derivatives and their biological properties. Bioorganic & Medicinal Chemistry Letters. 2(5). 445–448. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Venkat R. Pallela Breakdown of academic impact, for papers by Susan Ashton Breakdown of academic impact, for papers by Cécile Combeau Breakdown of academic impact, for papers by Ashutosh Pal Breakdown of academic impact, for papers by Satish K. Chitneni Breakdown of academic impact, for papers by Diane Teague Breakdown of academic impact, for papers by Mark D. Hylarides Breakdown of academic impact, for papers by Mark Frigerio Breakdown of academic impact, for papers by K. M. Błażewska Breakdown of academic impact, for papers by Sylvia Musto
Rankless by CCL
2026